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Abstract  Obesity  is  a  serious  disorder  in  almost  the  entire  world.  It  is  an  important  risk  factor
for a  series  of  conditions  that  affect  and  threaten  health.  Currently,  bariatric  surgery  is  the
most effective  treatment  for  morbid  obesity,  and  in  addition  to  the  resulting  weight  loss,  it
reduces morbidity  in  this  population.  There  has  been  a  signiﬁcant  increase  in  the  number  of
obese patients  operated  on.  Despite  the  success  of  bariatric  surgery,  an  important  group
of patients  still  present  with  major  postoperative  complications.  In  order  for  endoscopy  to
effectively  contribute  to  the  diagnosis  and  treatment  of  complications  deriving  from  obesity
surgery, the  gastroenterologist  must  be  aware  of  the  particularities  involved  in  bariatric  surgery.
The present  article  is  a  review  of  the  resulting  anatomic  aspects  of  the  main  surgical  techniques
employed,  the  most  common  postoperative  symptoms,  the  potential  complications,  and  the
possibilities  that  endoscopic  diagnosis  and  treatment  offer.  Endoscopy  is  a  growing  and  con-
tinuously evolving  method  in  the  treatment  of  bariatric  surgery  complications.  The  aim  of  this
review is  to  contribute  to  the  preparation  of  gastroenterologists  so  they  can  offer  adequate
endoscopic  diagnosis  and  treatment  to  this  high-risk  population.
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Manejo  endoscópico  de  las  complicaciones  en  la  cirugía  bariátrica:  lo  que  el
gastroenterólogo  debe  saber
Resumen  La  obesidad  es  un  transtorno  grave  en  casi  todo  el  mundo.  Representa  un  impor-
tante factor  de  riesgo  para  una  serie  de  condiciones  que  afectan  y  amenazan  la  salud.  En  la
actualidad,  la  cirugía  bariátrica  es  el  tratamiento  más  eﬁcaz  de  la  obesidad  mórbida  y  resulta
además de  la  pérdida  de  peso  en  la  redución  de  morbilidad  en  esta  población.  El  número  de
pacientes obesos  operados  se  ha  incrementado  signiﬁcativamente.  A  pesar  del  éxito  de  la  cirugía
bariátrica,  un  grupo  de  pacientes  presentará  complicaciones  mayores  en  el  postoperatorio.
Para que  la  endoscopia  contribuya  en  el  diagnóstico  y  tratamiento  de  las  complicaciones  de
la cirugía  de  la  obesidad,  es  necesario  que  el  gastroenterólogo  esté  familiarizado  con  las
particularidades  de  la  cirugía  bariátrica.  En  el  presente  artículo  revisamos  los  aspectos  anatómi-
cos resultantes  de  las  principales  técnicas  quirúrgicas  empleadas,  los  síntomas  más  comunes
en el  postoperatorio,  las  ponteciales  complicaciones  y  las  posibilidades  de  diagnóstico  y  de
tratamiento  endoscópico.  La  endoscopia,  en  el  tratamiento  de  las  complicaciones  de  la  cirugía
bariátrica,  es  un  área  que  está  en  crecimiento  y  en  continua  evolución.  El  objetivo  de  esta
revisión es  contribuir  para  la  preparación  de  los  gastroenterólogos  para  que  ofrezcan  diagnóstico
y tratamiento  endoscópico  adecuado  a  esta  población  de  alto  riesgo.
© 2015  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Este es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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limit  its  emptying,  and  when  examined  endoscopically,  it  is
viewed  as  a  12  mm  annular  impression  at  the  most  distal
portion  of  the  pouch.  The  gastrojejunal  anastomosis  has  antroduction
he  prevalence  of  obese  patients  has  increased  worldwide1.
besity  is  associated  with  a  series  of  conditions  that
hreaten  health,  and  therefore  is  a  serious  public  health
roblem2,3.  Clinical  treatment  has  no  long-term  satis-
action  for  an  important  fraction  of  obese  patients4,5.
urgical  treatment  is  considered  efﬁcacious  in  relation  to
eight  loss,  maintaining  that  loss,  and  improving  long-
erm  morbidities6,7.  The  number  of  bariatric  surgeries  has
ncreased  systematically  each  year8.  Bariatric  surgery
as  a  mortality  rate  lower  than  1%  in  referral  centers9,
ith  an  estimated  5-10%  of  the  patients  having  acute
omplications  and  9-25%  late  complications10.  Endoscopic
tudy  after  obesity  surgery  has  well-deﬁned  indications  for
ymptom  evaluation,  the  diagnosis  of  complications,  and
ventually  for  therapeutic  procedures11,12.  In  order  for  endo-
copic  study  to  contribute  to  the  diagnosis  and  treatment
f  complications  deriving  from  obesity  surgery,  adequate
nowledge  of  the  anatomic  aspects  resulting  from  the  sur-
ical  techniques  employed  is  necessary,  as  well  as  their
otential  complications  and  management13,14.
ndoscopic aspects of banded Roux-en-Y
astric bypass (Capella surgery)
or  many  years,  the  most  widely  used  technique  was  the
apella  surgery15,  in  which  the  stomach  is  stapled  and  sec-
ioned  forming  a  small  reservoir  next  to  the  cardia,  called
he  gastric  pouch.  The  rest  of  the  stomach,  duodenum,  and
art  of  the  proximal  jejunum  are  excluded  from  food  transit.
t  is  reconstituted  with  an  end-to-side  anastomosis  between
he  gastric  pouch  and  a  Roux-en-Y  loop  of  the  jejunal  seg-
ent  (ﬁg.  1).  At  endoscopy,  the  gastric  pouch  begins  just
F
(elow  the  esophagogastric  transition  and  extends  for  5-7  cm.
ometimes  the  suture  line  of  the  gastric  section  can  be  seen.
 synthetic  band  is  placed  externally  around  the  pouch  toigure  1  Anatomic  aspect  of  banded  Roux-en-Y  gastric  bypass
Capella).
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tFigure  2  Anatomic  aspect  of  Roux-en-Y  gastric  bypass.
diameter  of  approximately  12-14  mm  and  is  observed  just
below  the  band.  The  afferent  segment  loop  is  short,  ends  in
a  blind  fundus,  has  a  sharp  angle  and  is  imbricated  at  the
suture  line  of  the  gastric  pouch  -  a  modiﬁcation  proposed
by  Fobi16.  The  efferent  segment  loop  is  long  and  remains
available  almost  at  the  same  axis  of  the  pouch.  The  endo-
scopist  must  be  aware  of  the  esophageal  mucosa,  the  size
and  integrity  of  the  gastric  pouch,  especially  at  the  suture
line,  the  positioning  and  caliber  of  the  band,  the  aspect  of
the  anastomosis,  and  the  proximal  jejunal  mucosa17,18.
Endoscopic aspects of the Roux-en-Y gastric
bypass
This  is  currently  the  most  frequently  performed  surgery  for
obesity  and  is  preferably  done  through  laparoscopy.  The
technique  is  practically  the  same  as  that  of  the  Capella
surgery,  but  with  no  band  placement  and  with  the  elabora-
tion  of  a  smaller  pouch,  especially  at  the  side  of  the  greater
curvature.  Either  an  end-to-end  or  end-to-side  anastomo-
sis  is  performed  with  a  reduced  caliber,  which  substitutes
the  restrictive  effect  of  a  band11,18 (ﬁg.  2).  The  endoscopic
aspect  is  similar  to  that  of  the  Capella  surgery  (banded  gas-
tric  bypass),  with  a  tendency  toward  a  smaller  pouch  and
p
w
i
s
Figure  3  Endoscopic  aspect  of  the  Roux-en-Y  gastric  bypaigure  4  Anatomic  aspect  of  the  vertical  gastrectomy  (Sleeve
astrectomy).
maller  caliber  anastomosis,  and  obviously  no  band  impres-
ion  is  observed17--19 (ﬁg.  3).
ndoscopic aspects of the vertical
astrectomy (Sleeve gastrectomy)
ertical  gastrectomy  is  a  purely  restrictive  technique.  The
reater  curvature  and  the  gastric  fundus  are  resected,
orming  a  vertical  tube  and  resulting  in  a  smaller  volume
tomach.  The  resection  is  done  7  cm  from  the  pylorus  up  to
he  His  angle  (ﬁg.  4).  At  endoscopy  we  observe  the  proximal
art  of  the  gastric  sleeve  tunneled  up  to  the  angular  incisura,
here  an  intentionally  constructed  angulation  is  noted  that
mpedes  gastric  emptying.  After  the  angulation,  the  con-
erved  antrum  and  duodenum  are  seen.  The  endoscopist
ss.  a)  Gastric  pouch.  b)  Gastrointestinal  anastomosis.
3 L.C.M.  da  Rocha  et  al.
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Table  1  Endoscopy  indications  in  218  patients  in  the  ﬁrst
year after  bariatric  surgery.
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hould  observe  the  esophageal  mucosa,  the  esophagogastric
pithelial  transition,  the  axis  of  the  tunneled  portion,  the
ransition  of  the  tunneled  portion  of  the  antrum,  and
he  antral  and  duodenal  mucosa17--19.
ndoscopy in the immediate postoperative
eriod
his  should  be  carried  out  with  care  and  a  minimum  insufﬂa-
ion  of  air,  even  though  it  rarely  results  in  complications20,21.
n  the  ﬁrst  postoperative  days,  endoscopy  is  hindered  by
dema  and  friability  of  the  regions  of  the  band  and  the
nastomosis.  Its  performance  could  be  imperative  if  there
s  bleeding,  manifested  as  hematemesis  or  melena.  Bleed-
ng  occurs  in  the  immediate  postoperative  period  in  1-5%
f  the  cases  of  gastric  bypass22,23.  One  study  demonstrated
hat  bleeding  presented  during  the  ﬁrst  4  h  in  70%  of
he  patients24,  but  it  is  rare  after  vertical  gastrectomy
r  band  laparoscopy25.  The  hemorrhage  rate  is  higher  in
aparoscopic  gastric  bypass  (5.1%)  than  in  access  through
aparotomy  (2.4%),  and  re-bleeding  is  also  greater  in  the
aparoscopic  group22.  In  a  review  of  933  patients  that  under-
ent  gastric  bypass,  the  rate  of  bleeding  was  3.2%.  Of
hose  patients,  47%  had  one  episode,  43%  had  2  episodes,
nd  10%  had  3  episodes23.  Endoscopic  examination  is  not
lways  necessary,  given  that  hemorrhage  can  be  mild  and/or
elf-limited.  If  bleeding  is  severe  or  recurrent  after  con-
ervative  management,  endoscopy  should  be  performed25.
leeding  commonly  arises  in  the  gastrointestinal  anasto-
osis,  with  the  possibility  of  endoscopic  hemostasis14,25.
he  use  of  endoclips  is  a  better  option,  compared  with
hermal  methods,  because  it  minimizes  the  lesion  in  the
nastomosis  and  should  be  accompanied  with  the  use  of
n  adrenalin  solution,  given  that  the  double  therapy  has
etter  results13,26.  In  a  review  of  89  patients  with  immedi-
te  post-bypass  bleeding,  77%  were  treated  conservatively
nd  diagnostic  and  therapeutic  endoscopy  was  performed  in
nly  6  (6.7%)  and  5  (5.6%)  of  those  patients,  respectively27.
n  another  report,  endoscopy  was  performed  on  27  out  of
0  patients  (90%),  and  bleeding  arose  from  the  gastrojeju-
al  anastomosis  in  all  the  cases23.  In  85%  of  those  patients,
here  was  active  bleeding  or  blood  stigmata,  and  thera-
eutic  endoscopy  with  injection,  thermal  coagulation,  or
ndoclip  placement  was  employed.  Bleeding  was  initially
ontrolled  in  all  the  patients,  but  5  (17%)  had  rebleeding  and
nderwent  repeat  therapeutic  endoscopy.  Less  commonly,
emorrhage  can  occur  at  the  section  line  of  the  gastric
ouch,  the  enteroenteric  anastomosis,  at  another  point  of
he  small  bowel  or  colon,  or  in  the  excluded  stomach11,13,28.
ndoscopy in the late postoperative period
his  can  be  performed,  in  the  absence  of  symptoms,  to  cer-
ify  and  evaluate  the  surgical  technique19.  This  indication  is
uestioned  by  some,  in  relation  to  cost-beneﬁt29. Endoscopy
ill  be  performed  in  20-30%  of  the  patients  in  the  pres-
nce  of  symptoms  that  may  occur19,30 that  mainly  include
bdominal  pain,  nausea  and  vomiting,  reﬂux  symptoms,  dys-
hagia,  and  weight-related  problems11,19,31,32.  Table  1  shows
he  endoscopy  indications  in  218  patients  in  the  ﬁrst  post-
perative  year32.  Esophagitis,  marginal  ulcer,  anastomosis
m
w
p
mClinical data 
tricture,  erosion,  band  slippage,  hemorrhages,  and  ﬁstu-
as  were  among  the  main  endoscopic  ﬁndings,  with  variable
ncidence  according  to  the  characteristics  of  the  patients
tudied13,14,19,21.
ausea and vomiting
hese  are  not  unusual  in  the  ﬁrst  days,  and  normally  last
round  one  week.  They  are  related  to  the  use  of  medi-
ations,  edema  of  the  anastomosis,  transitory  dysmotility,
r  more  frequently,  to  a combination  of  these  factors33.
hen  they  do  not  disappear  or  improve  enough  to  allow
he  ingestion  of  liquids,  endoscopy  is  indicated31.  These
re  complaints  that  also  occur  after  the  ﬁrst  postopera-
ive  weeks  and,  in  themselves,  are  not  an  indication  for
ndoscopic  study14.  In  general,  there  is  a  tendency
or  improvement  in  regard  to  vomiting  within  1-6  months,
nd  close  to  75%  of  patients  will  no  longer  present  with
omiting,  or  if  so,  only  sporadically34.  Characterizing  the
omiting  is  important  in  relation  to  aspect,  if  it  is  the  clear
aliva  type  or  if  there  are  food  residues,  in  relation  to  fre-
uency,  if  it  is  constant  or  postprandial,  in  relation  to  the
umber  of  episodes,  its  association  with  sialorrhea,  dyspha-
ia,  or  pain,  and  its  correlation  with  surgery  duration33,34.
ndoscopy  indication  should  take  these  factors  into  account
o  that,  on  the  one  hand,  unnecessary  studies  are  avoided,
nd  on  the  other,  diagnosis  of  stricture  of  the  band  or  anas-
omosis,  or  even  of  food  impaction,  can  be  made11,12,19.
nadequate weight loss
eight  loss  is  greater  in  the  ﬁrst  6  months  and  decreases
fter  that  period.  It  is  expected  to  be  mild  and  constant  up
o  12  or  15  months,  reaching  up  to  a  45%  loss  of  the  ini-
ial  weight6,7. Some  patients  may  regain  from  5-10%  of  their
eight  loss  2-4  years  after  surgery,  which  is  acceptable35.  It
s  estimated  that  from  18-30%  of  the  patients  can  regain
lmost  all  the  weight  lost,  characterizing  surgical  treat-
ent  failure35,36.  Even  if  inadequate  results  in  relation  to
eight  loss  are  related  to  dietary,  behavioral,  or  hormonal
roblems37, alterations  susceptible  to  endoscopic  manage-
ent  may  be  involved.  Endoscopy  is  indicated  when  there  is
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FFigure  5  Argon  plasma  fulguration.  a)  Aspect  of  the  anastomo
catheter (2l/min  and  90Watts  of  potency).  d)  Final  aspect  after
insufﬁcient  or  exaggerated  weight  loss  or  when  more  weight
than  the  weight  that  was  lost  is  regained38.  When  there  is
insufﬁcient  loss,  diagnosis  may  be  ﬁstulas  between  the  gas-
tric  pouch  and  the  anastomosed  segment  (gastrojejunal)  or
between  the  pouch  and  the  excluded  stomach  (gastrogas-
tric)  and  partial  or  total  band  erosion.  Large  pouches  and
dilated  anastomoses  can  also  be  correlated  with  insufﬁcient
weight  loss13,19,39.  There  are  cases  of  endoscopic  interven-
tions  on  the  dilated  anastomosis  to  reduce  its  caliber  and
induce  weight  loss  with  the  injection  of  sclerosants40,  argon
gas  fulguration41,  (ﬁg.  5),  and  endoclip  application42.  Uti-
lizing  these  methods,  64%  of  patients  can  lose  up  to  75%  of
the  regained  weight43,44.  There  are  reports  of  experimental
endoscopic  interventions  with  different  suturing  platforms
for  reducing  the  diameter  of  the  anastomosis  or  the  size  of
the  pouch.  These  techniques  include  plicatures  with  systems
such  as  the  EndoCinth45,  Apollo  OverStitch46,  StomaphyX47,
Rose,  and  BOB48.  Likewise,  endoscopic  treatment  of  the  gas-
trogastric  and  gastrointestinal  ﬁstulas  is  possible  through
suturing  with  these  same  systems13,48,49.  These  different
approaches  are  successful  in  inducing  weight  loss  in  75%
of  the  patients48,50,51.  Nevertheless,  the  long-term  effect  of
these  procedures  on  the  anastomosis  and  the  maintenance
of  these  plicatures  is  not  known.  Thus,  further  studies  are
needed  to  determine  the  impact  of  these  procedures,  keep-
ing  in  mind  that  weight  loss  is  multifactorial13,48.
Marginal ulcer
Marginal  or  anastomotic  mouth  ulcer  can  occur  after  gas-
tric  bypass  for  obesity,  and  is  described  both  within  the  ﬁrst
days  and  many  years  after  the  surgery52.  Incidence  varies
from  0.5-20%12,53 and  depends  on  a  series  of  factors.  These
include  the  frequency  with  which  exploratory  endoscopy  is
carried  out,  the  time  at  which  it  is  done,  and  the  empiri-
cal  treatment  rate  before  endoscopy12,53.  The  incidence  of
marginal  ulcer  was  greater  in  cases  in  which  the  2  gastric
chambers  were  not  sectioned,  given  that  the  sleeves  were
able  to  be  rechanneled,  allowing  the  acid  from  the  excluded
stomach  to  directly  reach  the  jejunal  mucosa54. With  the
transection  of  the  2  gastric  chambers  and  the  interlaying
of  the  segment  between  them,  the  possibility  of  ﬁstula  is
rare54,  reducing  the  incidence  of  ulcer11,13.  Another  techni-
cal  aspect  to  consider  is  the  fact  that  a  large  gastric  pouch
would  have  a  greater  production  of  acid  and  a  greater  prob-
ability  of  ulcer54.  The  current  tendency  of  a  small  pouch
reduces  that  incidence52,55.  Likewise,  marginal  ulcer  occurs
in  0-6%  of  bypass  surgeries30,55.  Some  surgeons  separate
the  marginal  ulcer  of  the  stoma  (of  the  suture  line,  gas-
tric  margin)  from  the  marginal  ulcer  (of  the  jejunal  mucosa,
P
p
eefore  the  fulguration.  b)  and  c)  Fulguration  with  argon  plasma
uration.
djacent  to  the  anastomosis)12,19. In  cases  of  marginal  ulcer,
elated  to  the  factors  described  above,  the  lesion  occurs
ater,  can  be  single  or  multiple,  and  is  located  in  the  jeju-
al  mucosa,  adjacent  to  the  anastomosis13.  The  ulcer  of
he  stoma  can  also  occur  due  to  technical  factors  related
o  anastomosis  and  Roux-en-Y  performance  and  not  as  a
esult  of  a  large  pouch,  ﬁstulas,  or  some  other  ulcerogenic
actor.  These  ulcers  are  generally  caused  by  the  presence
f  a  foreign  body  (suture  thread)  at  the  suture  line52,55,
iminished  blood  supply  in  the  jejunal  mucosa,  compression
nd  edema  in  the  anastomosis,  or  tension  due  to  a  short
esentery55,56.  These  ulcers  occur  in  the  early  postopera-
ive  period  and  are  observed  at  the  suture  line,  sometimes
n  a surgical  thread,  and  they  cicatrize  in  2  or  3  months,
ainly  if  the  causal  agent  is  removed56,57.  Other  factors
elated  to  marginal  ulcer  etiology  are  smoking,  alcoholism,
nd  the  use  of  acetylsalicylic  acid  and  anti-inﬂammatory
rugs52--56.  Some  studies  have  analyzed  the  effect  of  Heli-
obacter  pylori  (H.  pylori) on  the  development  of  ulcers
fter  bariatric  surgeries11,13.  Serology  is  the  best  method  for
etecting  H.  pylori  in  this  population,  because  pouch  biop-
ies  and  breath  tests  can  give  false  negatives13,56.  The  rate
f  infection  in  gastric  bypass  surgery  is  low  and  its  role  in
he  origin  of  marginal  ulcer  is  not  yet  well  deﬁned12,52,56.
herefore,  investigating  the  bacterium  in  the  pouch  and
ts  treatment  can  only  be  done  empirically.  Abdominal  pain
s  the  most  common  symptom  in  patients  with  ulcer11--13.
ausea  and  vomiting  can  be  present,  with  or  without  pain,
nd  massive  bleeding  is  uncommon52.  Diagnosis  is  immi-
ently  endoscopic.  Early  ulcers,  related  to  problems  at  the
uture  line,  tend  to  spontaneously  cicatrize52,56. Recurrent
r  persistent  ulceration,  associated  with  the  presence  of
 foreign  body,  can  be  treated  through  endoscopic  extrac-
ion  of  the  foreign  body57,58. The  endoscopist  can  remove
uture  threads  when  they  are  visible  in  the  lumen  and  if
hey  are  associated  with  a  marginal  ulcer.  This  behavior
otentially  facilitates  cicatrization  and  thus  alleviates  symp-
oms  of  abdominal  pain25. Ulcers  caused  by  problems  in  the
ouch  construction,  normally  located  in  the  jejunal  mucosa,
hould  be  treated  with  proton  pump  inhibitors  together  with
ucralfate.  Cicatrization  time  can  vary  from  8  weeks  to
 months12,13,56.  A  review  of  the  surgical  procedure  is  nec-
ssary  in  cases  of  gastrogastric  ﬁstulas  or  large  pouches  and
lcer  intractability12,13,53.
ood bolus impactionatients  that  undergo  Capella  surgery  have  a  small  gastric
ouch  whose  emptying  is  limited  by  the  silicon  band.  In  Roux-
n-Y  gastric  bypass  with  no  band,  the  anastomosis  has  a
40  L.C.M.  da  Rocha  et  al.
F bypa
c n.
s
I
i
p
t
o
n
t
a
b
s
a
t
c
c
a
A
b
t
b
t
e
t
i
t
d
t
S
S
g
i
g
a
I
w
f
d
d
w
a
s
w
t
t
i
i
s
(
p
a
t
a
t
e
o
N
a
u
t
a
I
n
i
h
S
c
n
N
m
m
o
1
i
s
I
t
o
t
e
i
B
c
e
t
(
g
b
t
t
p
aigure  6  Dilation  of  the  anastomosis  stricture  after  gastric  
) Progressive  balloon  dilation.  d)  Final  aspect  after  the  dilatio
maller  caliber  and  also  limits  the  emptying  of  the  pouch.
n  some  situations,  through  error  or  dietary  abuse,  difﬁculty
n  chewing,  or  stricture  of  the  anastomosis  or  band,  these
atients  can  present  with  impacted  food  or  food  boluses  in
he  pouch.  In  these  cases,  the  patient  complains  of  sial-
rrhea,  dysphagia,  odynophagia,  and  the  sudden  onset  of
ausea  and  vomiting19,59.  Some  patients  state  they  have  par-
ial  and  temporary  improvement  after  vomiting  and  they  are
ble  to  drink  small  quantities  of  water,  which  can  proba-
ly  be  explained  by  a  valvular  mechanism.  Endoscopic  study
hould  be  performed  with  special  care  to  avoid  bronchial
spiration59.  The  food  bolus  that  is  normally  free  in  the  gas-
ric  pouch  can  be  made  of  meat,  fruit  seeds,  or  other  less
ommon  foods.  The  endoscopist  must  evaluate  the  size  and
onsistency  of  the  impacted  material  and  choose  the  best
ccessory  and  most  adequate  technique  for  its  removal59,60.
 polypectomy  loop,  Dormia  basket,  or  biopsy  or  foreign
ody  forceps  can  be  used  and  the  food  bolus  can  be  removed
hrough  the  oral  cavity,  fragmented,  and  pushed  beyond  the
and  and  the  anastomosis,  or  aspirated  with  an  elastic  liga-
ure  cap59,60.  During  or  after  removal  of  the  food  bolus,  the
ndoscopist  must  carry  out  a  complete  endoscopic  examina-
ion,  searching  for  obstructive  alterations  that  explain  the
mpaction.  It  is  important  to  identify  the  alteration  because
his  will  determine  the  behavior  to  be  adopted:  a  simple
ietary  reorientation  or  endoscopic  or  surgical  resolution  of
he  obstructive  factor19,59.
tricture of the anastomosis and the band
tricture  of  the  gastrojejunal  anastomosis  in  Roux-en-Y
astric  bypass  has  a  frequency  of  3-19%61--63.  This  variation
s  partially  explained  by  the  differences  in  technique64. In
astric  bypass  with  no  band,  a  lower  caliber  anastomosis  is
ttempted  and  the  incidence  of  stricture  is  slightly  higher65.
ncidence  is  higher  with  the  laparoscopic  access  (5-12%)  than
ith  open  surgery  (3-5%)62,66.  Stricture  generally  derives
rom  some  complication  of  the  surgical  technique,  such  as:
ehiscence,  hematoma,  or  ulceration,  processes  that  pro-
uce  ﬁbrosis  and  retraction13,19,67.  The  patient  can  present
ith  eating  difﬁculties,  especially  with  solid  foods,  as  well
s  nausea  and  vomiting,  between  4  and  10  weeks  after
urgery60,65,67.  The  endoscopic  aspect  is  of  an  anastomosis
ith  annular  stricture,  ﬁbrotic,  with  a  punctiform  caliber
hat  impedes  the  passage  of  the  endoscope13,67,  and  some-
imes  with  an  ulcer  in  the  adjacent  mucosa67.  Treatment
s  endoscopic  through  dilations  with  hydrostatic  balloons
ntroduced  through  the  working  channel  of  the  endo-
cope  and  allowing  the  passage  of  a  thread-guidewire67--69
B
O
bss.  a)  Passage  of  the  guidewire  through  the  stricture.  b)  and
ﬁg.  6).  The  balloon  must  be  carefully  passed  through  the
unctiform  stricture,  because  the  blind  afferent  segment
nd  the  intestinal  portion  of  the  anastomosis  are  distal  to
he  stricture13,67.  Likewise,  to  prevent  complications,  such
s  perforation,  which  occur  in  an  average  of  2.2%  of  cases67,
he  balloon  should  be  carefully  passed  in  the  direction  of  the
fferent  segment;  this  is  facilitated  by  the  previous  passage
f  a  guidewire  that  can  be  monitored  by  ﬂuoroscopy11.
ormally,  initial  dilation  can  reach  up  to  15  mm,  the  same
s  in  punctiform  strictures70.  However,  progressive  dilation,
p  to  12  mm  in  the  ﬁrst  session  and  13.5  and  15  mm  in
he  subsequent  sessions  performed  after  7 or  15  days,
ppears  to  be  safer  and  with  a  lower  complication  rate11,12.
n  gastric  bypass  with  no  band,  some  authors  recommend
ot  to  exceed  12-13  mm,  considering  the  possibility  that
t  could  result  in  a  very  wide  anastomosis,  which  could
ave  a long-term  impact  on  weight  loss71,72.  Dilation  with
avary-Gilliard  dilators  has  been  reported  and  in  a  review
omparing  the  2  methods,  the  result  was  similar,  with  a
eed  for  2  or  3  dilations  and  a  3%  complication  rate67.
evertheless,  progressive  dilation  with  a guided  balloon,
ainly  in  punctiform  strictures,  appears  to  be  safer  and
ore  effective13,73.  The  majority  of  cases  are  resolved  in  2
r  a  maximum  of  3  sessions,  with  a  resolution  rate  of  95  to
00%67--69,74.  The  smaller  caliber  band  leading  to  stricture
s  less  common,  occurring  in  1-2%  of  the  patients21.  Clinical
ymptoms  are  similar  to  those  of  anastomosis  stricture.
n  the  endoscopic  examination,  there  is  intense  edema  in
he  mucosa  in  the  region  of  the  anastomosis  and  no  aspect
f  ﬁbrosis  or  cicatrization,  suggesting  that  there  is  very
ight  extrinsic  band  compression.  Sometimes,  when  the
ndoscope  approaches  the  band,  it  is  possible  to  distally
dentify  the  line  of  the  normal  caliber  anastomosis32.
alloon  dilation  up  to  20  mm  is  not  effective  and  eventually
an  worsen  symptoms  due  to  the  inﬂammatory  reaction  and
dema  caused  by  the  compression  of  the  mucosa  against
he  band75.  One  option  is  dilation  with  an  achalasia  balloon
30  mm),  positioned  like  a Savary-Gilliard  guidewire76.  The
oal  is  the  rupture  of  the  thread  that  internally  sustains  the
and  or  simply  the  deﬁnitive  increase  in  the  diameter  due  to
he  elasticity  of  the  thread  (ﬁg.  7).  It  is  a complex  technique
hat  should  be  performed  under  ﬂuoroscopy  and  its  main
otential  complication  is  perforation.  In  addition  to  this
lternative,  surgical  treatment  should  also  be  considered.and migration and slippage
ne  band  complication  is  ulceration  of  the  mucosa  due  to
and  compression  and  its  partial  or  total  migration  into
Endoscopic  management  of  bariatric  surgery  complications:  what  the  gastroenterologist  should  know  41
Figure  7  Band  dilation  after  gastric  bypass  surgery.  a)  Band  stricture.  b)  and  c)  Progressive  balloon  dilation  of  30  mm.  d)  Final
aspect after  dilation.
Figure  8  Removal  of  band  migrating  into  the  pouch  lumen  after  gastric  bypass  surgery.  a)  Migrated  band.  b)  Passage  of  the
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fguidewire through  the  band.  c)  Band  sectioning  with  the  lithotri
in place.  d)  Band  after  its  removal.
the  gastric  lumen.  In  large  case  series,  overall  incidence
of  band  migration  to  the  lumen  is  around  1.6%21,59.  This
complication  occurs  in  0.9%  of  the  primary  surgeries,  in  5.5%
of  the  re-interventions,  and  in  28.5%  of  the  surgeries  with
band  replacement  after  previous  band  migration77.  Band
migration  begins  with  an  inﬂammatory  reaction  between
the  band  and  the  gastric  wall.  Its  cause  is  very  tight  place-
ment  of  the  band,  suturing  of  the  band  to  the  stomach,
or  the  presence  of  local  infection75.  This  complication  can
be  asymptomatic  or  can  more  commonly  present  as  a syn-
drome  of  obstruction,  causing  nausea,  vomiting,  and  weight
loss.  Other  possible  symptoms  are  epigastric  pain,  dyspha-
gia,  and  more  rarely  anemia,  hematemesis,  or  melena32.
Endoscopy  enables  a  precise  diagnosis,  showing  the  erosion
or  ulceration  with  partial  band  migration.  Treatment  can
be  surveillance,  endoscopy,  or  surgery.  Surveillance  may  be
indicated  in  those  asymptomatic  patients  with  satisfactory
weight  loss  and  in  whom  only  a  small  portion  of  the  band  has
migrated.  Removal  is  the  treatment  of  choice78.  Normally,
the  band  is  sectioned  with  endoscopic  scissors  or  a  guidewire
ﬁt  to  a  mechanical  lithotripsy  system  (ﬁg.  8),  in  the  same
way  as  the  removal  of  the  migrated  gastric  band78,79.  Some-
times  the  aid  of  an  extra  channel  in  the  endoscope  is
necessary26.  Another  possibility  for  removing  the  migrated,
eroded,  or  strictured  band  is  passing  a  self-expanding  stent
that  induces  complete  band  migration  and  then  6-8  weeks
later,  remove  the  stent  and  the  ring  together79,80.  One  must
be  alert  as  to  the  possibility  of  the  formation  of  a  ﬁs-
tula,  though  rarely  described,  that  is  most  likely  due  to
the  intense  ﬁbrotic  process  surrounding  the  region  that
also  makes  surgical  treatment  technically  difﬁcult13,32.  The
effect  of  band  removal  on  weight  loss  and  maintenance  of
that  loss  is  not  yet  deﬁned.  Weight  regain  (from  61-75%
of  the  weight  previously  lost)  can  occur  in  close  to  14%  of
patients  when  the  band  is  removed  within  the  ﬁrst  6  months,
compared  with  6%  when  removal  is  after  that  period77.  Band
o
c
o
(ystem  (left)  and  foreign  body  forceps  (right),  holding  the  band
lippage  is  an  even  rarer  complication  and  occurs  in  less
han  1%  of  the  cases21,59. Inadequate  band  attachment  can
ead  to  displacement,  usually  of  the  anterior  portion,  up
o  the  region  of  the  anastomosis.  The  clinical  symptom  is
bstruction,  with  vomiting  and  excessive  weight  loss60.  The
and  can  be  seen  out  of  its  habitual  position  through  radio-
raphic  imaging.  The  endoscopic  aspect  is  characteristic;
he  pouch  is  a  bit  dilated  with  no  annular  compression  of  its
ost  distal  portion,  the  jejunal  mucosa  is  partially  everted,
nd  the  compression  of  the  band  at  some  portion  of  the  seg-
ent  can  be  observed,  leading  to  a  punctiform  stricture75.
n  general,  the  endoscope  cannot  pass  and  food  residuals
an  be  seen  in  the  pouch  and  even  in  one  of  the  segments.
echniques  of  band  dilation  with  a  30  mm  achalasia  balloon76
r  the  placement  of  a  stent  have  been  described  for  treat-
ng  this  complication78,80, but  surgical  band  removal  is  more
requently  performed.
istulas
he  incidence  of  ﬁstulas  in  bariatric  surgery  varies  with  the
echnique,  the  number  of  patients,  and  the  period  analyzed,
nd  whether  the  case  series  describe  endoscopic  or  surgi-
al  procedures.  It  was  previously  estimated  from  0.4-26%  of
he  cases21,49,81. However,  thanks  to  surgical  improvements,
here  was  a  signiﬁcant  decrease  in  this  rate  and  ﬁstulas
re  currently  estimated  to  occur  in  2.05-5.2%  of  patients
fter  laparoscopic  gastric  bypass,  in  1.68-2.60%  after  open
ypass,  and  in  0.6-7%  after  vertical  gastrectomy82--85.  This
ncidence  can  reach  up  to  8%  when  the  surgery  is  per-
ormed  due  to  conversion  from  another  technique59.  It  is
ne  of  the  most  serious  complications  and  is  the  second
ause  of  death  from  bariatric  surgery,  with  a  mortality  rate
f  up  to  1.5%86,87.  Fistulas  can  be  gastrocutaneous,  internal
gastrogastric  or  gastroenteric)  or  they  can  be  considered
42  L.C.M.  da  Rocha  et  al.
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gastrocutaneous  ﬁstula  that  can  lead  to  closure  or  con-
tribute  to  a  quicker  resolution  is  suggested,  reducing
hospitalization  and  morbidity86. Fistula  closure  can  require
occlusion,  not  only  of  the  ﬁstulous  oriﬁce,  but  also  of
the  entire  tract.  This  has  been  attempted  with  the  endo-
scopic  injection  of  substances,  such  as  biologic  or  synthetic
glues,  placement  of  an  acellular  matrix  in  the  form  of
strips  or  cones  on  the  tract  or  at  the  ﬁstulous  oriﬁce,
application  of  endoclips,  and  in  special  cases,  the  place-
ment  of  self-expanding  stents13,14,86. More  commonly,  a
combination  of  techniques  is  employed.  In  order  to  indi-
cate  endoscopic  ﬁstula  treatment,  it  is  necessary  to  make
sure  that  the  ﬁstula  maintenance  factor  has  been  resolved,
such  as  infection,  foreign  body,  and  distal  obstruction.  One
of  the  endoscopic  ﬁstula  treatment  options  after  bariatric
surgery  is  the  placement  of  partially  or  totally  covered  self-
expanding  stents86,89.  In  the  case  of  post-bariatric  surgery
ﬁstulas,  it  is  necessary  to  use  special  stents  that  can  be
removed90. Plastic  stents  were  initially  used,  followed  by
metal  ones89,90.  The  covered  self-expanding  stent  forms
a  physical  barrier  between  the  ﬁstula  and  the  endolumi-
nal  content,  favoring  cicatrization,  while  enabling  enteral
nutrition91. Poli  et  al.92,  reviewed  67  cases  of  ﬁstulas  after
Roux-en-Y  gastric  bypasses,  duodenal  switch  vertical  gas-
trectomies,  and  banded  vertical  gastroplasties  treated  with
stent  placement.  The  results  showed  ﬁstula  closure  in  87.7%igure  9  Gastrocutaneous  ﬁstulas  after  bariatric  surgery.  a)
ypass. b)  Post-vertical  gastrectomy.
omplex,  affecting  the  gastric  pouch  and  an  adjacent  or  dis-
ant  organ87.  Gastrocutaneous  ﬁstula  occurs  after  an  early
ymptom  of  abdominal  sepsis  due  to  peritonitis  or  local-
zed  abscess  and  is  treated  with  surgical  intervention  and/or
rainage87.  Clinical  manifestation  is  late  in  the  gastrogastric
r  gastrointestinal  ﬁstula,  with  inadequate  weight  loss  or
eight  regain,  epigastric  pain  (due  to  marginal  ulcer),  and
eﬂux,  but  it  can  be  subclinical,  asymptomatic,  and  with
atisfactory  weight  loss13.  Endoscopy  deﬁnes  the  presence
f  the  ﬁstulous  oriﬁce  and  characterizes  it  in  relation  to  its
ocation,  size  of  the  internal  oriﬁce,  and  the  presence  of  a
oreign  body  (suture  thread)  in  the  adjacent  mucosa.  Gastro-
utaneous  ﬁstula  occurs  more  commonly  in  the  gastrojejunal
nastomosis  and  in  the  upper  portion  of  the  suture  line  of  the
astric  pouch  (bypass)  or  the  gastric  sleeve  (gastrectomy),
djacent  to  the  esophagogastric  transition  (ﬁg.  9),  most  cer-
ainly  due  to  a  vascularization  deﬁciency  at  that  point14,87.
e  observed  a  wide  communication  in  the  internal  ﬁstula
ith  the  intestinal  segment  or  with  the  excluded  stomach
ﬁg.  10).  In  the  2  locations,  distal  stricture  can  be  diag-
osed,  related  to  the  band  and  the  anastomosis  in  the  gastric
ypass  or  excessive  angulation  at  the  ﬁnal  portion  of  the
unneled  zone  of  the  vertical  gastrectomy.  These  are  con-
idered  factors  that  predispose  to  and  maintain  ﬁstulas86.
ndoscopy  can  identify  other  alterations,  such  as  internal
igration  of  the  band  in  the  bypass,  tortuosity  and  dilation
f  the  tubular  portion  in  the  vertical  gastrectomy,  and  the
resence  of  mucosal  septa  adjacent  to  the  ﬁstulous  oriﬁce.
ontrast-enhanced  study  of  the  ﬁstula  can  be  carried  out
o  demonstrate  and  delimit  the  ﬁstulous  tract,  diagnose  the
ommunication  with  other  organs,  diagnose  complex  ﬁstu-
as,  and  especially,  to  evaluate  emptying  difﬁculty  related  to
he  strictures  distal  to  the  ﬁstula13,19.  Fistulas  after  bariatric
urgeries  are  treated  with  nutritional  support,  suppression
f  gastrointestinal  secretions,  treatment  of  infection,  and
urgical  excision  of  the  ﬁstulous  oriﬁce14.  Endoscopy  can
elp  in  these  general  measures  with  procedures  such  as
he  passage  of  a  nasoenteric  tube  to  enable  nutrition,  thus
xcluding  transit  in  the  region  of  the  ﬁstula,  removal  of  for-
ign  bodies  in  the  region  of  the  oriﬁce,  placement,  traction,
nd  repositioning  of  the  drains  or  probes  in  the  cavities  and
ollections,  and  especially,  treating  eventual  strictures  dis-
al  to  the  ﬁstula84.  This  type  of  treatment  is  of  considerable
alue  and  enables  closure  of  up  to  85%  of  the  ﬁstulas88.
evertheless,  sometimes  this  approach  can  be  delayed,
xpensive,  or  may  not  achieve  the  expected  success.  In  such
ases,  endoscopic  treatment  speciﬁcally  directed  at  the
Figure  10  Large  gastrogastric  ﬁstula  with  partial  band  migra-
tion after  gastric  bypass  surgery.
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bEndoscopic  management  of  bariatric  surgery  complications:
of  the  cases,  with  a  range  between  79-94%  (95%  conﬁdence
interval).  The  time  interval  between  stent  placement  and
removal  varied  between  one  and  2  months  in  the  majority
of  studies.  Six  of  the  67  patients  (9%)  underwent  surgical
treatment  after  closure  failure  with  the  placement  of  up
to  two  stents.  There  was  stent  migration  in  16.9%  of  the
cases,  related  to  stent  design  or  type  of  surgery  and  not  to
the  endoscopic  placement  technique.  Endoscopic  removal
of  the  stents  was  possible  in  almost  92%  of  the  cases  and
the  causes  of  failure  were  tissue  hyperplasia  and  migra-
tion.  There  are  reports  on  the  difﬁculty  of  stent  removal,
with  serious  complications  such  as  bleeding,  removal  in
pieces,  and  even  mucosectomy.  There  are  cases  of  plas-
tic  stent  placement  inside  the  metallic  stent  to  facilitate
its  removal93.  Considering  the  difﬁculties  and  complications
of  removal,  the  migration  rate,  and  the  different  anatomic
details  of  the  surgical  techniques,  it  will  be  necessary  to
develop  speciﬁc  stents  to  be  used  in  post-bariatric  surgery
ﬁstulas86,91.  Even  though  ﬁstula  treatment  with  stents
appears  promising,  there  are  not  yet  enough  controlled
data  to  recommend  their  routine  use14,90.  These  accessories
should  have  differentiated  size  and  caliber  (adapted  to  the
surgical  anatomy),  an  anti-migration  system,  and  a  safe
removal  mechanism,  or  be  biodegradable13,86,90.  Finally,  it
appears  that  the  tendency  for  endoscopy’s  role  in  relation
to  ﬁstulas  involves  2  situations:  ﬁrst,  in  the  placement  of
stents  in  early  cases93,  and  second,  in  the  rigorous  dila-
tion  of  eventual  distal  strictures  in  the  chronic  cases19.
In  the  cases  of  gastrointestinal  and  gastrogastric  ﬁstulas,
classic  treatment  is  surgical,  and  the  morbidity  and  mor-
tality  can  be  two  times  higher  than  in  the  ﬁrst  surgery.
Taking  into  account  the  problems  of  surgical  re-operations,
as  well  as  ﬁstula  closure  failure,  endoscopic  treatment  is
suggested.  In  the  last  few  years,  studies  with  small  case
series  or  case  reports  have  shown  the  possibility  of  endo-
scopic  suture  of  these  defects,  utilizing  accessories  such
as  the  Endo-Cinch94,  special  clips  (Ovesco)95,  StomaphyX96,
and  Apollo  OverStitch97,  or  the  attempt  to  close  the  oriﬁce
utilizing  a  stent,  biologic  glue,  debridement  through  argon
plasma  coagulation,  and  sometimes  using  a  combination  of
two  or  more  methods90.  All  the  techniques  have  been  shown
to  be  feasible,  although  the  durability  of  these  endoscopic
sutures  needs  further  evaluation  and  long-term  follow-up,
especially  in  large  communications  between  the  pouch  and
the  stomach  and/or  intestine86,90.
Choledocolithiasis
The  incidence  of  biliary  lithiasis  after  bariatric  surgery
is  high,  most  certainly  due  to  rapid  weight  loss98.  Up  to
36%  of  the  patients  develop  cholecystolithiasis,  generally
within  the  ﬁrst  6  postoperative  months99.  Approximately
30%  of  surgeons  perform  cholecystectomy  during  bariatric
surgery  in  patients  with  a  normal  gallbladder19,100.  Oth-
ers  regard  this  conduct  as  unjustiﬁable101.  Considering  the
high  incidence  of  biliary  lithiasis  in  the  patients  oper-
ated  on,  when  these  patients  present  with  symptoms
and  have  laboratory  and  ultrasound  studies  suggestive  of
lithiasis,  magnetic  resonance  cholangiography  should  be
systematically  carried  out  to  make  the  diagnosis  of  chole-
docholithiasis  that  occurs  in  4.7-7%  of  these  patients11.
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he  standard  nonsurgical  treatment  for  choledocholithia-
is  is  through  endoscopic  cholangiography  and  papillotomy.
his  approach  is  limited  in  gastric  bypass  surgery  because
ral  access  is  impossible.  Some  techniques  have  been
roposed  for  performing  endoscopic  cholangiography  and
apillotomy  after  gastric  bypass.  This  approach  can  be  endo-
copic  or  a  combination  of  laparoscopy  and  endoscopy13,102.
olutions  include  balloon  enteroscopy,  percutaneous  gas-
rostomy  in  the  excluded  stomach,  or  laparoscopic-assisted
ransgastric  endoscopic  access103--107. There  is  an  84%  suc-
ess  rate  using  enteroscopy19,106,107.  The  disadvantages  of
his  method  are  the  lack  of  accessories  with  a  length
ompatible  with  the  enteroscope,  the  lack  of  an  eleva-
or,  and  frontal  vision  limitations  of  the  endoscope  for
iliopancreatic  therapy19.  Percutaneous  gastrostomy,  per-
ormed  through  radiologic  methods  or  at  the  time  of
ariatric  surgery,  offers  multiple  access  possibilities,  but
equires  time  to  mature  and  produces  some  discomfort
ince  it  cannot  be  rapidly  removed102.  Among  the  options,
aparoscopy-assisted  transgastric  endoscopic  cholangiogra-
hy  and  papillotomy  has  been  reported  as  the  best  option.
t  has  a  high  success  rate  and  is  a  low-risk  procedure,
specially  in  cholecystectomized  patients.  This  technique
s  safe,  reproducible,  utilizes  known  and  available  equip-
ent  and  accessories,  and  standardized  laparoscopic  and
ndoscopic  techniques102,104,105.  If  the  patient  presents  with
holecystolithiasis  and  choledocolithiasis  in  the  postopera-
ive  period,  the  surgeon  should  perform  cholecystectomy
nd  can  treat  the  choledocolithiasis  through  surgery  or  the
ombined  approach  of  cholecystectomy  plus  the  creation  of
 transgastric  access  for  endoscopic  papillotomy11,12.  There
re  technical  variations  in  this  method  that  include  the  man-
er  in  which  the  surgeon  prepares  and  performs  the  access
o  the  stomach  (using  sutures,  a  trocar,  or  another  tube)  and
ow  the  endoscopist  passes  and  positions  the  duodenoscope
directly  or  guided  by  the  surgeon)102.
he excluded stomach in gastric bypass
he  excluded  stomach  in  gastric  bypass  surgery  can-
ot  be  examined  through  the  usual  endoscopic  or
adiographic  techniques108. Gastroduodenoscopy,  using  a
ediatric  colonoscope,  introduced  in  a  retrograde  manner
hrough  the  jejunal  segment  to  the  excluded  segment  was
uccessfully  performed  in  86%  of  77  attempts109.  However,  it
ppears  to  us  that  this  technique  is  only  possible  in  selected
ases  when  a  gastrojejunostomy  is  used  for  reconstruction
nd  in  the  cases  of  short  Roux-en-Y  with  ample  enteroenteric
atero-lateral  anastomosis.  The  method  of  access  through
 long  segment  is  at  present  practically  impossible.  Some
tudies  have  reported  on  successful  and  safe  access  to  the
xcluded  stomach  through  the  use  of  the  balloon  entero-
cope  (simple  or  double)110,111. Indications  for  this  method
ary  and  include  epigastric  pain,  anemia,  excessive  weight
oss,  active  bleeding,  and  occult  bleeding.  In  an  analysis
f  12  patients  with  occult  bleeding  and  anatomy  altered
y  Roux-en-Y,  6  for  gastric  bypass,  the  main  ﬁndings  were
lcer  of  the  anastomosis,  peri-anastomotic  neovasculariza-
ion,  and  Dieulafoy’s  lesion112.  In  contrast,  in  another  case
eries  of  enteroscopy  in  35  patients  with  Roux-en-Y,  but
ndicated  due  to  epigastric  pain,  the  predominant  ﬁndings
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ere  erosions  and  ulcers  in  the  stomach  in  35%  of  the
atients  and  few  diagnoses  of  ulcers  and  peri-anastomotic
eovascularization113.  One  patient  with  gastric  bypass  for
0  years  presented  with  melena  and  severe  anemia  and  the
xamination  of  the  Roux-en-Y  excluded  stomach  through
ouble  balloon  endoscopy  revealed  severe  hemorrhagic  ero-
ive  pangastritis  that  was  adequately  treated  with  high  doses
f  proton  pump  inhibitors114.  Some  case  series,  in  which
xamination  of  the  excluded  stomach  was  possible,  reported
uperﬁcial  chronic  gastritis  in  87%  of  patients  that  was
istologically  conﬁrmed  in  42%,  with  10%  presenting  with
ntestinal  metaplasia;  the  meaning  of  these  ﬁndings  was  not
lear110,111.  Acid  production  was  lower  than  in  the  normal
opulation  and  H.  pylori  was  negative  in  70%  of  the  cases,
uggesting  that  the  excluded  stomach  is  less  ulcerogenic108.
evertheless,  peptic  ulcer  can  occur  in  the  excluded  stom-
ch,  including  perforation  or  bleeding,  with  an  incidence
nder  0.3%113,115.  The  average  time  between  surgery  and
 hemorrhagic  episode  is  a  mean  of  9.5  years.  There  are
eports  in  a  literature  review  of  ﬁve  cases  of  gastric  can-
er  in  a  gastric  bypass  excluded  stomach,  one  case  13  years
fter  the  surgery,  three  cases  9  years  after  the  surgery,  and
ne  case  5  years  after  the  surgery116.  It  has  an  extremely
ow  incidence,  considering  the  large  number  of  bariatric  sur-
eries  performed.  Thus  it  is  estimated  that  less  than  1%  of
atients  have  a  real  necessity  for  endoscopic  study  of  the
xcluded  stomach108,109.
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